XP19986: Phase I data

In a 2-stage, double-blind, placebo-controlled, single-dose, U.S. Phase I trial in healthy adult volunteers, all 3 XP19986 formulations, 1 immediate-release (IR) and 2 sustained-release (SR), were wel...